Citations

Clear

6273 citation(s) found for "To, Andrew".

Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report
Ralya, Andrew T., Baruchel, Sylvain , Wu, Bing , Liu, Xiaowei , Fox, Elizabeth , Weigel, Brenda J. , Blaney, Susan M. , Reid, Joel M. , Leary, Sarah , Park, Julie R. , Roberts, Timothy P. L. , Minard, Charles G.

Mayo Clinic

Clinical Cancer Research | July 28, 2017 | Volume: 23 | Issue: 20 | Pages: 6062-6069

10.1158/1078-0432.ccr-16-2882 | PMID 28751444 Get It

Abstract Purpose: Trebananib is a first-in-class antiangiogenic peptibody (peptide–Fc fusion protein) that inhibits Angiopoietin 1 and 2. A pediatric phase 1 trial was performed to define trebananib dose-limiting toxicities (DLT), recommended phase 2 dose (RP2D), and pharmacokinetics (PK). Experimental Design: Trebananib was administered by weekly infusion. Three dose levels (10, 15, or 30 mg/kg/dose) were evaluated using a rolling-six design. Part 2 evaluated a cohort of subjects with primary central nervous system (CNS) tumors. Pharmacokinetic sampling and analysis of peripheral blood biomarkers was performed during the first 4 weeks. Response was evaluated after 8 weeks. Correlative studies included angiogenic protein expression and DCE-MRI. Results: Thirty-seven subjects were enrolled (31 evaluable for toxicity) with median age 12 years (range, 2 to 21). Two of 19 evaluable non-CNS subjects developed DLT at the 30 mg/kg dose level, including venous thrombosis and pleural effusion. In the CNS cohort, 3/12 subjects developed DLT, including decreased platelet count, transient ischemic attack, and cerebral edema with headache and hydrocephalus. Other grade 3 or 4 toxicities included lymphopenia (n = 4), anemia, thrombocytopenia, neutropenia, vomiting, and hypertension (n = 1 each). Response included stable disease in 7 subjects, no partial or complete responses. Two subjects continued study treatment with prolonged stable disease for 18 cycles (neuroblastoma) and 26 cycles (anaplastic astrocytoma). Pharmacokinetics appeared linear over 3 dose levels. Correlative studies demonstrated increased PlGF and sVCAM-1, but no change in endoglin or perfusion by DCE-MRI. Conclusions: Trebananib was well tolerated in pediatric patients with recurrent or refractory solid or CNS tumors. RP2D is 30 mg/kg. Clin Cancer Res; 23(20); 6062–9. ©2017 AACR.
Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study
Kinnunen, Kirsi M. , Cash, David M. , Poole, Teresa, Frost, Chris , Benzinger, Tammie L.S. , Ahsan, R. Laila, Leung, Kelvin K., Cardoso, M. Jorge , Modat, Marc , Malone, Ian B. , Morris, John C. , Bateman, Randall J. , Marcus, Daniel S. , Goate, Alison , Salloway, Stephen , Correia, Stephen , Chhatwal, Jasmeer P. , Mayeux, Richard , Martins, Ralph N. , Farlow, Martin R. , Saykin, Andrew J. , Jack, Clifford R. , Schofield, Peter R. , Weiner, Michael W. , Ringman, John M. , Thompson, Paul M. , Masters, Colin L. , Rossor, Martin N. , Ourselin, Sébastien , Fox, Nick C. , (DIAN), Dominantly Inherited Alzheimer Network, Sperling, Reisa Anne , Brickman, Adam M. , Ghetti, Bernardino , McDade, Eric , Rowe, Christopher Cleon , (DIAN), Dominantly Inherited Alzheimer Network, Jack, Clifford R , Saykin, Andrew J , Schofield, Peter R , Thompson, Paul M , Bateman, Randall J , Masters, Colin L , Benzinger, Tammie L S , Fox, Nick C , Morris, John C , Cash, David M , Goate, Alison M

Mayo Clinic

Alzheimer's & Dementia | July 22, 2017 | Volume: 14 | Issue: 1 | Pages: 43-53

10.1016/j.jalz.2017.06.2268 | PMID 28738187 Get It

Abstract Introduction Identifying at what point atrophy rates first change in Alzheimer's disease is important for informing design of presymptomatic trials. Methods Serial T1‐weighted magnetic resonance imaging scans of 94 participants (28 noncarriers, 66 carriers) from the Dominantly Inherited Alzheimer Network were used to measure brain, ventricular, and hippocampal atrophy rates. For each structure, nonlinear mixed‐effects models estimated the change‐points when atrophy rates deviate from normal and the rates of change before and after this point. Results Atrophy increased after the change‐point, which occurred 1–1.5 years (assuming a single step change in atrophy rate) or 3–8 years (assuming gradual acceleration of atrophy) before expected symptom onset. At expected symptom onset, estimated atrophy rates were at least 3.6 times than those before the change‐point. Discussion Atrophy rates are pathologically increased up to seven years before “expected onset”. During this period, atrophy rates may be useful for inclusion and tracking of disease progression.
Pathology Imagebase—a reference image database for standardization of pathology
Egevad, Lars , Cheville, John C. , Evans, Andrew , Hörnblad, Jonas, Kench, James G. , Leite, Kátia Ramos Moreira , Pan, Chin‐Chen , Samaratunga, Hemamali , Srigley, John R., True, Lawrence D. , Zhou, Ming , Clements, Mark , Delahunt, Brett , Panel, The ISUP Pathology Imagebase Expert, Cheng, Liang , López-Beltrán, Antonio , Távora, Fábio , Netto, George J. , Tsuzuki, Toyonori , Pan, Chin-Chen , Delahunt, Brett , Kristiansen, Glen , Magi‐Galluzzi, Cristina , Panel, The ISUP Pathology Imagebase Expert, Tsuzuki, Toyonori , Samaratunga, Hemamali , Cheng, Liang

Mayo Clinic

Histopathology | July 19, 2017 | Volume: 71 | Issue: 5 | Pages: 677-685

10.1111/his.13313 | PMID 28722802 Get It

AimsDespite efforts to standardize histopathology practice through the development of guidelines, the interpretation of morphology is still hampered by subjectivity. We here describe Pathology Imagebase, a novel mechanism for establishing an international standard for the interpretation of pathology specimens.Methods and resultsThe International Society of Urological Pathology (ISUP) established a reference image database through the input of experts in the field. Three panels were formed, one each for prostate, urinary bladder and renal pathology, consisting of 24 international experts. Each of the panel members uploaded microphotographs of cases into a non‐public database. The remaining 23 experts were asked to vote from a multiple‐choice menu. Prior to and while voting, panel members were unable to access the results of voting by the other experts. When a consensus level of at least two‐thirds or 16 votes was reached, cases were automatically transferred to the main database. Consensus was reached in a total of 287 cases across five projects on the grading of prostate, bladder and renal cancer and the classification of renal tumours and flat lesions of the bladder. The full database is available to all ISUP members at www.isupweb.org. Non‐members may access a selected number of cases.ConclusionsIt is anticipated that the database will assist pathologists in calibrating their grading, and will also promote consistency in the diagnosis of difficult cases.
Rhinomanometry for Preoperative and Postoperative Assessment of Nasal Obstruction
Gordon, Andrew S.D., McCaffrey, Thomas V., Kern, Eugene B. , Pallanch, John F.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | July 18, 2017 | Volume: 101 | Issue: 1 | Pages: 20-26

10.1177/019459988910100105 | PMID 2502759 Get It

In this retrospective study we used active, anterior mask rhinomanometric methods to measure nasal resistance before and after surgery for nasal obstruction. The study group comprised 60 patients with nasal obstruction who had 63 preoperative and postoperative rhinomanograms and the control group contained 14 asymptomatic patients who underwent rhinomanometric studies before transnasal, transsphenoidal pituitary surgery. Before surgery the study group had significantly higher total and combined unilateral nasal resistances than either the control group before surgery (p < 0.05 and p < 0.01, respectively) or the study group after surgery (p < 0.0001 for both comparisons). Surgery normalized the nasal resistances of the study group in relation to the control group. A total nasal resistance greater than 1 cm H2O/L/sec or a unilateral resistance greater than 3.5 cm H2O/L/sec suggests clinically significant nasal obstruction. Airway narrowing and obstructive symptoms correlated with airway resistance in the preoperative patient, but symptoms did not correlate well with postoperative resistance.
Standardized Approach for ROI-Based Measurements of Proton Density Fat Fraction and R2* in the Liver
Campo, Camilo A. , Bookwalter, Candice A., Pay, Andrew J. Van, Hernando, Diego , Schubert, Tilman B. , Reeder, Scott B.

Mayo Clinic

American Journal of Roentgenology | July 13, 2017 | Volume: 209 | Issue: 3 | Pages: 592-603

10.2214/ajr.17.17812 | PMID 28705058 Get It

Correction: The complex genetics of gait speed: genome-wide meta-analysis approach
Ben-Avraham, Dan, Karasik, David , Verghese, Joe , Lunetta, Kathryn L. , Eicher, John D., Vered, Rotem, Deelen, Joris , Arnold, Alice M. , Buchman, Aron S. , Faul, Jessica D. , Nethander, Maria , Fornage, Myriam , Adams, Hieab H.H. , Matteini, Amy M., Callisaya, Michele L. , Smith, Albert V. , Yu, Lei, Jager, Philip L. De , Evans, Denis A., Guðnason, Vilmundur , Hofman, Albert , Pattie, Alison, Knopman, Davis S., Parimi, Neeta, Bandinelli, Stefania , Beekman, Marian , Gutman, Danielle , Sharvit, Lital , Mooijaart, Simon P. , Liewald, David C. , Houwing‐Duistermaat, Jeanine J. , Ohlsson, Claes , Moed, Matthijs, Hernandez, Dena, Thomson, Russell , Tranah, Gregory J. , Weir, David R. , Zhao, Wei , Starr, John M. , Johnson, Andrew D. , Bennett, David A. , Cummings, Steven R. , Deary, Ian J. , Harris, Tamara B., Kardia, Sharon L. R., Mosley, Thomas H. , Srikanth, Velandai , Windham, B. Gwen , Davies, Gail , Evans, Daniel S. , Ferrucci, Luigi , Atzmon, Gil , Bennett, David A. , Turner, Stephen T. , Smith, Jennifer A. , Tanaka, Toshiko , Corley, Janie , Launer, Lenore J. , Verlinden, Vincentius J.A. , Mellström, Dan , Geest, Jos N. van der , Karlsson, Magnus K , McWhirter, Rebekah , Liu, Ching‐Ti , Uitterlinden, André G. , Ikram, M. Arfan , Newman, Anne B. , Walston, Jeremy D , Slagboom, P. Eline , Kiel, Douglas P. , Murabito, Joanne M. , Adams, Hieab H H , Smith, Albert V , Ferrucci, Luigi , Ohlsson, Claes , Srikanth, Velandai K

Mayo Clinic

Aging | July 7, 2017 | Volume: 9 | Issue: 7 | Pages: 1844-1846

10.18632/aging.101260 | PMID 28696945 Get It

Accuracy of Resting Metabolic Rate Prediction Equations in Athletes
Jagim, Andrew R. , Camic, Clayton L., Kisiolek, Jacob N. , Luedke, Joel, Erickson, Jacob L. , Jones, Margaret T. , Oliver, Jonathan M. , Erickson, Jacob, Jagim, Andrew R

Mayo Clinic

Journal of Strength and Conditioning Research | July 6, 2017 | Volume: 32 | Issue: 7 | Pages: 1875-1881

10.1519/jsc.0000000000002111 | PMID 28682934 Get It

Abstract Jagim, AR, Camic, CL, Kisiolek, J, Luedke, J, Erickson, J, Jones, MT, and Oliver, JM. Accuracy of resting metabolic rate prediction equations in athletes. J Strength Cond Res 32(7): 1875–1881, 2018—The purpose of this study was to determine the accuracy of 5 different resting metabolic rate (RMR) prediction equations in male and female athletes. Twenty-two female (19.7 ± 1.4 years; 166.2 ± 5.5 cm; 63.5 ± 7.3 kg; 49.2 ± 4.3 kg of fat-free mass (FFM); 23.4 ± 4.4 body fat (BF) percent) and 28 male (20.2 ± 1.6 years; 181.9 ± 6.1 cm; 94.5 ± 16.2 kg; 79.1 ± 7.2 kg of FFM; 15.1 ± 8.5% BF) athletes were recruited to participate in 1 day of metabolic testing. Assessments comprised RMR measurements using indirect calorimetry, and body composition analyses using air displacement plethysmography. One-way repeated-measures analysis of variance with follow-up paired t tests were selected to determine differences between indirect calorimetry and 5 RMR prediction equations. Linear regression analysis was used to assess the accuracy of each RMR prediction method. An alpha level of p ≤ 0.05 was used to determine statistical significance. All the prediction equations significantly underestimated RMR while the Cunningham equation had the smallest mean difference (−165 kcals). In men, the Harris-Benedict equation was found to be the best prediction formula with the lowest root-mean-square prediction error value of 284 kcals. In women, the Cunningham equation was found to be the best prediction equation with the lowest root-mean-squared error value of 110 kcals. Resting metabolic rate prediction equations consistently seem to underestimate RMR in male and female athletes. The Harris-Benedict equation seems to be most accurate for male athletes, whereas the Cunningham equation may be better suited for female athletes.
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States
Muffly, Lori , Pasquini, Marcelo C. , Martens, Michael J. , Brazauskas, Ruta , Zhu, Xiaochun , Adekola, Kehinde , Aljurf, Mahmoud , Ballen, Karen K. , Baron, Frédéric , Beitinjaneh, Amer , Cahn, Jean‐Yves, Carabasi, Mathew, Chen, Yi‐Bin , Ciurea, Stefan O. , Copelan, Edward A. , D’Souza, Anita , Edwards, John , Foran, James M. , Freytes, César O. , Fung, Henry C., Hashmi, Shahrukh K. , Hildebrandt, Gerhard , Ho, Vincent T. , Jakubowski, Ann A. , Luskin, Marlise R. , Martino, Rodrigo , Olin, Rebecca L. , Olsson, Richard F. , Pawarode, Attaphol , Peres, Edward, Rezvani, Andrew R. , Rizzieri, David A. , Schouten, Harry C. , Sabloff, Mitchell , Seftel, Matthew D. , Seo, Sachiko , Sorror, Mohamed L. , Wirk, Baldeep , Wood, William A. , Bajel, Ashish R. , Battiwalla, Minoo , Cahn, Jean‐Yves , Chhabra, Saurabh , Gale, Robert Peter , Giralt, Sergio , Lazarus, Hillard M. , Luskin, Marlise R , Maziarz, Richard Thomas , McCarthy, Philip L. , Nishihori, Taiga , Savani, Bipin N. , Szer, Jeff , Artz, Andrew , D'Souza, Anita , Olsson, Richard F , Martino, Rodrigo , Muffly, Lori , Sabloff, Mitchell , Martens, Michael J , Sorror, Mohamed , Wood, William A

Mayo Clinic

Blood | July 3, 2017 | Volume: 130 | Issue: 9 | Pages: 1156-1164

10.1182/blood-2017-03-772368 | PMID 28674027 Get It

Key Points Over the last decade, allogeneic HCT has been increasingly administered in the United States to adults aged 70 and older with hematologic malignancies. Allogeneic transplant outcomes were reasonable; high comorbidity and ablative conditioning regimens were associated with inferior outcomes.